Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20180725040597N1Phase 3Completed
Phase 3, randomised, triple-blind trial comparing Intravenous paracetamol, Meperidine and Placebo (3 arms). Primary endpoint: Shivering score. Started Feb 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20180725040597N1.